Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service bariatric surgery cases in New York: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 8% on average (98 state-years, 2020–2024): read it as a direction with a margin.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 11 | 861 | 46% |
| 2020 | 6 | 526 | 48% |
| 2021 | 2 | 593 | 51% |
| 2022 | 4 | 539 | 53% |
| 2023 | 3 | 464 | 55% |
| 2024 | 0 | 318 | 57% |
| 2025 from claims | – | 197 160–232 | 58% |
| 2026 forecast | – | 199 156–250 | 58% |
| 2027 forecast | – | 200 149–265 | 59% |
| 2028 forecast | – | 201 143–278 | 59% |
| 2029 forecast | – | 202 137–290 | 60% |
| 2030 forecast | – | 203 133–301 | 60% |
Gastric bypass, sleeve gastrectomy, gastric banding: mostly patients under 65. Professional codes (what the surgeon bills): CPT 43644, 43775, 43770; the hospital bills MS-DRG 619, 620, 621.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 100% inpatient hospital.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
No metro breakdown yet.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Massachusetts | 0 | 230−14%/yr | −14%/yr | 0.2 | 0% | 190 in 2030−2.8%/yr |
| Pennsylvania | 0 | 197−22%/yr | −22%/yr | 0.1 | 0% | 190 in 2030−0.9%/yr |
| New Jersey | 0 | 168−20%/yr | −20%/yr | 0.2 | 0% | 120 in 2030−5%/yr |
| New Hampshire | 0 | 103−3.3%/yr | −3.3%/yr | 0.4 | 0% | 90 in 2030−2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 131 | 10,502−1.8%/yr | −1.8%/yr | 6.11.0× | 7% | 11,800 in 2030+1.9%/yr |
| Cholecystectomy & appendectomy | 96 | 5,762−3.7%/yr | −3.7%/yr | 3.30.9× | 2% | 6,020 in 2030+0.7%/yr |
| Colorectal resection | 15 | 2,669−5%/yr | −5%/yr | 1.50.9× | 0% | 2,770 in 2030+0.6%/yr |
| Breast reconstruction | 6 | 970−6.9%/yr | −6.9%/yr | 0.51.5× | 7% | 1,170 in 2030+3.2%/yr |
| Antireflux & hiatal hernia surgery | 15 | 966−1.7%/yr | −1.7%/yr | 0.50.8× | 0% | 1,220 in 2030+4%/yr |
Bariatric surgery in every state, and its device makers · Every procedure market in New York · Every state · Compare with Massachusetts
Medtronic leads with 55% of company spending on these surgeons in 2025, +7 pts on 2024.
In 2025, 4 companies reported engagement with New York’s surgeons worth $83K in consulting, speaking, meals and travel tied to these products. Royalties are left out.
FDA, last 12 months: 5 clearances and approvals in the category.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
New York’s own discharge file counts every inpatient stay, whatever the payer: 4,675 gastric bypass stays at 59 hospitals in 2024, against the Medicare-only figures above. The most commercial of the busy ones is HIGHLAND HOSPITAL (75% commercial): where commercial rates leave the most room for a premium product.
| Hospital | Cases | Medicare | Commercial |
|---|---|---|---|
| BELLEVUE HOSPITAL CENTER NEW YORK | 711 | 3% | 38% |
| MONTEFIORE MEDICAL CENTER BRONX | 425 | 13% | 32% |
| NYU LANGONE HOSPITALS NEW YORK | 349 | 16% | 44% |
| CROUSE HOSPITAL SYRACUSE | 273 | 12% | 45% |
| NEW YORK-PRESBYTERIAN HOSPITAL NEW YORK | 248 | — | 37% |
| MOUNT SINAI WEST NEW YORK | 223 | 49% | 48% |
| WYNN HOSPITAL UTICA | 197 | 9% | 43% |
| MOUNT SINAI HOSPITAL NEW YORK | 122 | 51% | 40% |
New York only: MedaRep has no other state’s all-payer file yet. Counted by principal procedure (Gastric bypass: bypass only: a sleeve gastrectomy is filed with every other gastrectomy, cancer included, so it is not counted.). Medicare here includes Medicare Advantage. A hospital with 10 or fewer such stays, or a payer share of 10 or fewer, is not shown. Source: New York State Department of Health, SPARCS de-identified inpatient discharges (health.data.ny.gov). The New York State Department of Health makes no representation, warranty or guarantee relating to the data or analyses derived from these data. Accessed 2026-11-11.